Australia markets open in 4 hours 38 minutes

The Cooper Companies, Inc. (COO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
400.35+2.23 (+0.56%)
As of 01:20PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close398.12
Bid400.81 x 800
Ask401.70 x 900
Day's range398.79 - 404.00
52-week range359.84 - 463.59
Avg. volume323,595
Market cap19.78B
Beta (5Y monthly)0.88
PE ratio (TTM)6.77
EPS (TTM)59.16
Earnings date02 Mar 2022 - 07 Mar 2022
Forward dividend & yield0.06 (0.02%)
Ex-dividend date20 Jan 2022
1y target est470.46
  • GlobeNewswire

    CooperCompanies to Present at the J.P. Morgan Healthcare Conference

    SAN RAMON, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022. Al White, President and CEO, will represent the Company in a virtual session scheduled to begin at 2:15 PM ET. A live webcast of the presentation will be available to all interested parties on the Investor Relations section of CooperCompanies’ website at The webcast will be available for 30 days follow

  • Zacks

    HSIC vs. COO: Which Stock Should Value Investors Buy Now?

    HSIC vs. COO: Which Stock Is the Better Value Option?

  • GlobeNewswire

    CooperCompanies Completes Acquisition of Generate Life Sciences®

    SAN RAMON, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it has completed the previously announced definitive purchase agreement to acquire Generate Life Sciences, a leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood & cord tissue), for a purchase price of approximately $1.6 billion. “We are excited to complete this transaction and welcome the Generate employees to